More Evidence that the Biotech Agenda is “Anything Goes”

Harvard’s Doug Melton is one of the nation’s foremost biotech researchers into embryonic stem cells. He was interviewed recently in Discover magazine. You need to be a subscriber to access the entire article. So, I have reprinted a few choice quotes from the piece below, which provide further evidence that therapeutic cloning will not long remain in the Petri dish. Scientists like Melton apparently believe that when it comes to science, anything goes. (HT, Dorinda C. Bordlee, executive director of the Bioethics Defense Fund.)

“What would happen if scientists injected human stem cells into a monkey embryo? What would grow? A human heart, a human brain, a toe?” ‘That,’ he says, ‘is a kind of new biology that I find a million times more interesting than these specious arguments over whether life begins at fertilization.’”

“I find that when most people say ethics what they really mean is morals, and that it has to do with their religious beliefs. No one’s really trying to do unethical things.”

“So now let’s look ahead: Fast-forward two generations from now, and I will contend that it will be possible, by medical advances, to make cloning a child by nuclear transfer safer than natural childbirth- that the cloned embryos will have a defect rate of less than 1%.” (My emphasis.)

“It would take too long to talk about the various religious views of why one should isolate embryonic stem cells, and not, and whether cloning should be allowed. I don’t really want to get into it, and the reason is I don’t think it’s fundamentally interesting. It largely has to do with the trivial concern of trying to put a tag on when life begins. What I do think is deeply interesting is the issue of chimeras.”

The interviewer asked Melton if there is any instance he can imagine that would simply cause him to halt stem cell experiment. “I think it’s uninteresting to live in a society where one is so afraid of the unknown that you won’t try new things. I’ll think about the dangers, because I haven’t thought about them enough. I should think about why one shouldn’t do that experiment.”

Dear Reader,

Can I be direct with you?

War abroad. Socialists on the rise. AI upending human life. Endless uproar online. The modern attention economy doesn’t want readers — it wants users enslaved to the tyranny of the present.

First Things is the antidote: literary excellence, timeless truths, and a fixed point of reference in a culture that has lost its bearings.

But we can’t do it without readers like you.

Our goal: Raise $150,000 by November 1 to sustain First Things in the year ahead.


Your gift anchors readers in the permanent things.

Make your Fall Campaign gift now using the button below.

GIVE NOW

If you have any questions or would like more information, please contact Giovanni Del Piero, Director of the Editor’s Circle, at gdelpiero@firstthings.com or 212-627-1985.

Next
YOU MIGHT ALSO LIKE

The Church in the Age of Therapy

Matthew Loftus

In 1966, Philip Rieff wrote in The Triumph of the Therapeutic that “Religious man was born to…

Canada’s Deadliest Blind Spot

Anna Farrow

On September 20, the Daily Mail ran a story with the provocative headline, “Our 83-year-old Christian grandmother…

The Faithful Joy of Dolly Parton and Fulton Sheen

Mike Aquilina

Dolly Parton and Fulton Sheen seem to have had little in common. She favored rhinestones; he wore…